Drug Profile
Factor VII biosimilar - Genexine/Handok
Alternative Names: GX-F7Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Genexine
- Developer Genexine; Handok Inc
- Class Blood coagulation factors; Recombinant fusion proteins; Serine endopeptidases
- Mechanism of Action Factor VII stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Haemophilia
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Haemophilia in South Korea (IV)
- 08 Sep 2013 Preclinical development is ongoing in South Korea
- 01 Jul 2013 Handok Pharmaceuticals is now called Handok Inc